Michael Serlin
Infectious Disease · Baltimore, MDNPI 1568488336
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,381 of the $29,962 with a category attached, or 78.0%. Viiv Healthcare Company accounts for 79.2% of it on its own, with 12 other manufacturers making up the rest. Among infectious disease clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $143.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$24K
- Gilead$4K
- Cepheid$440
- Johnson & Johnson$409
- AbbVie$401
- Merck$333
- plus $357 from 7 others
What the payments were for
- Consulting fees$23,38178%
- Speaking & faculty fees$4401%
- Travel & lodging$1,8996%
- Food & beverage$4,04113%
- Education$2001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 91 | $23,725 |
| Gilead | 54 | $4,296 |
| Cepheid | 1 | $440 |
| Johnson & Johnson | 15 | $409 |
| AbbVie | 18 | $401 |
| Merck | 19 | $333 |
| Janssen Products, LP | 2 | $200 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Global Blood Therapeutics, Inc. | 2 | $30 |
| Novo Nordisk | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Theratechnologies Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$2,760
How this compares
$29,962 in reported general payments places this provider in the 90th percentile of 289 infectious disease providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 13 | $8,173 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,410 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $5,495 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,644 |
| Atorvastatin Calcium | 29 | $188 |
| Amitriptyline Hcl | 14 | $151 |
| Gabapentin | 23 | $149 |
| Omeprazole | 17 | $76 |
| Trazodone Hcl | 11 | $61 |
| Carvedilol | 17 | $53 |
| Pantoprazole Sodium | 12 | $43 |
| Sertraline Hcl | 13 | $35 |
| Amlodipine Besylate | 17 | $16 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Baltimore
- Robert RedfieldBaltimore$779K
- Luciana BorioBaltimore$671K
- Mark SulkowskiBaltimore$240K
- Jonathan ZenilmanBaltimore$202K
- Robert EdelmanBaltimore$125K
- Kjell WibergBaltimore$113K
- Christine DurandBaltimore$53K
- Myron LevineBaltimore$51K
- Robert BollingerBaltimore$50K
- Richard BergBaltimore$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.